Home » Topics » BioWorld Science

BioWorld Science
RSS

Jmackem divulges new TRPV1 antagonists

Nov. 15, 2021

LPAR1 antagonist PIPE-791 promotes remyelination in multiple sclerosis

Nov. 15, 2021

Fitness cost of antibiotic-resistant mutants can be used to identify new combination therapies

Nov. 12, 2021

ITIH4 is a marker for early diagnosis of gastric cancer

Nov. 12, 2021

Opus Genetics licenses new preclinical program for inherited retinal disease

Nov. 12, 2021

Study shows gut microbiome changes may be effect, not cause, of autism spectrum disorders

Nov. 12, 2021

Rakovina presents data on in vitro activity of novel dual PARP-HDAC inhibitors

Nov. 12, 2021

Circulating levels of galectin-1 associated with lower kidney function

Nov. 12, 2021

Cannabigerol derivatives have anti-inflammatory, analgesic and antiobesity potential

Nov. 12, 2021

DDR1 promotes immune exclusion in tumors and it is a therapeutic target

Nov. 12, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...
Initial data hint that US MFN pricing is hitting access in Europe
BioWorld
There are initial signs that President Donald Trump’s most-favored nation (MFN) policy may be further delaying access to new drugs in Europe, as companies hold...